Literature DB >> 16197510

A similar impairment in CA3 mossy fibre LTP in the R6/2 mouse model of Huntington's disease and in the complexin II knockout mouse.

Helen E Gibson1, Kerstin Reim, Nils Brose, A Jennifer Morton, Susan Jones.   

Abstract

Complexin II is reduced in Huntington's disease (HD) patients and in the R6/2 mouse model of HD. Mice lacking complexin II (Cplx2-/- mice) show selective cognitive deficits that reflect those seen in R6/2 mice. To determine whether or not there is a common mechanism that might underlie the cognitive deficits, long-term potentiation (LTP) was examined in the CA3 region of hippocampal slices from R6/2 mice and Cplx2-/- mice. While associational/commissural (A/C) LTP was not significantly different, mossy fibre (MF) LTP was significantly reduced in slices from R6/2 mice and Cplx2-/- mice compared with wild-type (WT) and Cplx2+/+ control mice. MF field excitatory postsynaptic potentials (fEPSPs) in response to paired stimuli were not significantly different between control mice and R6/2 or Cplx2-/- mice, suggesting that MF basal glutamate release is unaffected. Forskolin (30 microm) caused an increase in glutamate release at MF synapses in slices from R6/2 mice and from Cplx2-/- mice that was not significantly different from that seen in control mice, indicating that the capacity for increased glutamate release is not diminished. Thus, R6/2 mice and Cplx2-/- mice have a common selective impairment of MF LTP in the CA3 region. Together, these data suggest that complexin II is required for MF LTP, and that depletion of complexin II causes a selective impairment in MF LTP in the CA3 region. This impairment in MF LTP could contribute to spatial learning deficits observed in R6/2 and Cplx2-/- mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16197510     DOI: 10.1111/j.1460-9568.2005.04349.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  10 in total

1.  Hypertension-induced synapse loss and impairment in synaptic plasticity in the mouse hippocampus mimics the aging phenotype: implications for the pathogenesis of vascular cognitive impairment.

Authors:  Zsuzsanna Tucsek; M Noa Valcarcel-Ares; Stefano Tarantini; Andriy Yabluchanskiy; Gábor Fülöp; Tripti Gautam; Albert Orock; Anna Csiszar; Ferenc Deak; Zoltan Ungvari
Journal:  Geroscience       Date:  2017-06-29       Impact factor: 7.713

Review 2.  The corticostriatal pathway in Huntington's disease.

Authors:  Carlos Cepeda; Nanping Wu; Véronique M André; Damian M Cummings; Michael S Levine
Journal:  Prog Neurobiol       Date:  2006-12-13       Impact factor: 11.685

3.  Acute in vivo genetic rescue demonstrates that phosphorylation of RIM1alpha serine 413 is not required for mossy fiber long-term potentiation.

Authors:  Ying Yang; Nicole Calakos
Journal:  J Neurosci       Date:  2010-02-17       Impact factor: 6.167

Review 4.  The role of dopamine in Huntington's disease.

Authors:  Carlos Cepeda; Kerry P S Murphy; Martin Parent; Michael S Levine
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

5.  Abnormal motor cortex plasticity in premanifest and very early manifest Huntington disease.

Authors:  Michael Orth; Sven Schippling; Susanne A Schneider; Kailash P Bhatia; Penelope Talelli; Sarah J Tabrizi; John C Rothwell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-10-13       Impact factor: 10.154

6.  Temporal separation of aggregation and ubiquitination during early inclusion formation in transgenic mice carrying the Huntington's disease mutation.

Authors:  Belvin Gong; Catherine Kielar; A Jennifer Morton
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

Review 7.  Mouse models of polyglutamine diseases: review and data table. Part I.

Authors:  Maciej Figiel; Wojciech J Szlachcic; Pawel M Switonski; Agnieszka Gabka; Wlodzimierz J Krzyzosiak
Journal:  Mol Neurobiol       Date:  2012-09-07       Impact factor: 5.590

8.  The PDE1/5 Inhibitor SCH-51866 Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's Disease.

Authors:  Vahri Beaumont; Larry Park; Arash Rassoulpour; Ulrike Dijkman; Taneli Heikkinen; Kimmo Lehtimaki; Outi Kontkanen; Rand Al Nackkash; Gillian P Bates; Melanie Gleyzes; Esther Steidl; Sylvie Ramboz; Carol Murphy; Maria G Beconi; Celia Dominguez; Ignacio Munoz-Sanjuan
Journal:  PLoS Curr       Date:  2014-02-13

Review 9.  The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies.

Authors:  Rebecca K Senter; Ayan Ghoshal; Adam G Walker; Zixiu Xiang; Colleen M Niswender; P Jeffrey Conn
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

10.  Kdm3b haploinsufficiency impairs the consolidation of cerebellum-dependent motor memory in mice.

Authors:  Yong Gyu Kim; Myeong Seong Bak; Ahbin Kim; Yujin Kim; Yun-Cheol Chae; Ye Lee Kim; Yang-Sook Chun; Joon-Yong An; Sang-Beom Seo; Sang Jeong Kim; Yong-Seok Lee
Journal:  Mol Brain       Date:  2021-07-03       Impact factor: 4.041

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.